Request an invite

Spinraza: how long were the pivotal tox studies?

nusinersen · SMN2 (ASO)
Longest pivotal study
53 weeks
“A one year (53 weeks) repeat dose toxicity study in juvenile cynomolgus monkeys with a 26-week recovery phase”
✓ VerifiedFDA pharmacology/toxicology review, p. 33Source ↗
Pivotal GLP studies
14- and 53-week IT bolus juvenile monkey; 13-week SC juvenile mouse; single-dose IT adult monkey
“The toxicity and pharmacokinetics (PK) of ISIS 396443 were evaluated following single IT bolus doses (up to 7 mg) in adult monkeys or following repeated IT bolus doses (weekly or every other week) for 14 (0.3, 1, or 3 mg/dose) and 53 (0.3, 1, or 4 mg/dose) weeks in juvenile monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Route in tox
Intrathecal lumbar bolus (monkey, clinical route); subcutaneous (mouse, rabbit) for systemic exposure
“CNS safety was assessed as part of the acute and subchronic toxicity studies in monkeys using IT lumbar bolus injection, the intended route of administration in man.”
✓ VerifiedFDA pharmacology/toxicology review, p. 71Source ↗

Same question, other oligonucleotides

Amvuttra

vutrisiran · TTR (siRNA)
40 weeks

Dawnzera

donidalorsen · Prekallikrein / KLKB1 (ASO)
39 weeks

Givlaari

givosiran · ALAS1 (siRNA)
39 weeks

Izervay

avacincaptad pegol · C5 (aptamer)
39 weeks

Kynamro

mipomersen · APOB (ASO)
52 weeks

Leqvio

inclisiran · PCSK9 (siRNA)
40 weeks

Macugen

pegaptanib · VEGF-165 (aptamer)
39 weeks

Onpattro

patisiran · TTR (siRNA)
39 weeks

Oxlumo

lumasiran · HAO1 (siRNA)
36 weeks

Qalsody

tofersen · SOD1 (ASO)
39 weeks

Qfitlia

fitusiran · Antithrombin / SERPINC1 (siRNA)
39 weeks

Redemplo

plozasiran · APOC3 (siRNA)
37 weeks

Rivfloza

nedosiran · LDHA (siRNA)
39 weeks

Rytelo

imetelstat · Telomerase (oligo)
39 weeks

Tegsedi

inotersen · TTR (ASO)
39 weeks

Viltepso

viltolarsen · DMD exon 53 (PMO)
39 weeks

Wainua

eplontersen · TTR (ASO)
39 weeks

Waylivra

volanesorsen · APOC3 (ASO)
39 weeks

Summary across all 24 oligonucleotides →